None listed
Conditions
Sponsors
Megurodoori Gastrointestinal Surgery Internal Medicine Clinic
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: ?Persons who defecate 3 to 7 days par week ?Persons with bifidobacteria in the intestines
Exclusion criteria
Exclusion criteria: 1) Subjects with severe hepatic, renal, heart, gastrointestinal, cerebrovascular, endocrine, metabolic or infection diseases. 2) Subjects with the history of gastrointestinal resection. 3) Subjects with gastrointestinal dysfunction such as irritable bowel syndrome or inflammatory bowel disease. 4) Subjects who use medicines or supplements that may influence feces frequency; e.g. antibiotics, probiotics, laxatives, antidiarrheals, fibers. 5) Subjects with milk allergy or lactose intolerance. 6) Subjects who participate another study. 7) Subjects who are judged inappropriate for the study by the investigator or the physician.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bifidobacterium occupancy in feces | — |
Secondary
| Measure | Time frame |
|---|---|
| Stool bacterial flora, stool bifidobacterial count, defecation frequency, the days of defecation, stool properties, defecation volume, strength of defecation, defecation time. | — |
Countries
Japan
Contacts
Public ContactYosuke Inaba
3H Clinical Trial Co., Ltd. Patient Recruitment Group
Outcome results
None listed